Bonesupport Holding AB

Research Bonesupport Holding AB (BONEX) on Bullrun: valuation model: 26.8% overvalued, market cap SEK 14.40B, P/E 68.1. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerBONEX
ExchangeST
CountrySweden
SectorHealthcare
IndustryMedical Instruments & Supplies
CurrencySEK
Valuation signal26.8% overvalued
Market capSEK 14.40B
P/E68.1
Financial periodQ2 2026
RevenueSEK 355.72M
Net incomeSEK 81.88M
Free cash flowSEK 64.60M
Gross margin90.8%

Valuation Snapshot

Bullrun's latest valuation model marks Bonesupport Holding AB as 26.8% overvalued; latest market cap is SEK 14.40B; P/E is 68.1.

Peer valuation comparison

Latest P/E is 68.13x versus a Healthcare sector median of 24.46x (178.5% above).

Latest P/E is 68.13x versus a Sweden median of 18.57x (266.9% above).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	SEK 1.17B	SEK 142.16M	n/a	92.6%	n/a	SEK 377.99M	SEK 11.68M	SEK 867.26M
FY2024	SEK 898.73M	SEK 133.75M	SEK 64.23M	92.6%	2.01	SEK 227.00M	SEK 14.59M	SEK 727.46M
FY2023	SEK 591.08M	SEK 245.02M	-SEK 19.08M	91.5%	3.74	SEK 167.35M	n/a	SEK 545.18M
FY2022	SEK 328.82M	-SEK 68.17M	-SEK 48.94M	90.5%	-1.06	SEK 201.28M	n/a	SEK 268.93M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	SEK 14.40B	68.1	n/a	n/a

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection;

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

ODINWELL AB (0AF) MEDIMI AB AK (79T) AddLife AB (publ) (ALIF-B) Bio-Works Technologies AB (BIOWKS) Dynavox Group (DYVOX) iZafe Group AB Series B (IZAFE-B) Ortivus AB ser. A (ORTI-A) Ortivus AB ser. B (ORTI-B) S2Medical AB (S2M) Stille AB (STIL) Synsam AB (SYNSAM) Camurus AB (0RD1)

Frequently asked questions

Is Bonesupport Holding AB overvalued or undervalued?

Bullrun's valuation model currently marks Bonesupport Holding AB as 26.8% overvalued.

What is Bonesupport Holding AB's market cap?

Bonesupport Holding AB's market capitalization is SEK 14.40B.

What is Bonesupport Holding AB's P/E ratio?

Bonesupport Holding AB's price-to-earnings (P/E) ratio is 68.1.

What does Bonesupport Holding AB do?

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.